Publications by authors named "Eric Prieur"

Claim this Profile
E
Evaluating Human Immune Responses for Vaccine Development in a Novel Human Spleen Cell-Engrafted NOD-SCID-IL2rγNull Mouse Model.
Stéphanie Ghosn, Soulaima Chamat, Eric Prieur, Antoine Stephan, Pierre Druilhe

Front Immunol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-level artemisinin-resistance with quinine co-resistance emerges in P. falciparum malaria under in vivo artesunate pressure.
Rajeev K Tyagi, Patrick J Gleeson, Ludovic Arnold, Rachida Tahar, Eric Prieur

BMC Med· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malaria elimination in Haiti by the year 2020: an achievable goal?
Paul Jacques Boncy, Paul Adrien, Jean Frantz Lemoine, Alexandre Existe, Patricia Jean Henry, Eric Prieur

Malar J· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-clinical assessment of novel multivalent MSP3 malaria vaccine constructs.
Gilles Bang, Eric Prieur, Christian Roussilhon, Pierre Druilhe

PLoS One· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine.
David W Porter, Fiona M Thompson, Tamara K Berthoud, Claire L Hutchings, Laura Andrews, Eric Prieur

Vaccine· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward the rational design of a malaria vaccine construct using the MSP3 family as an example: contribution of immunogenicity studies in models.
Lena-Juliette Daher, Corine G Demanga, Eric Prieur, Jean-Louis Pérignon, Hasnaa Bouharoun-Tayoun

Infect Immun· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward the rational design of a malaria vaccine construct using the MSP3 family as an example: contribution of antigenicity studies in humans.
Corine G Demanga, Lena-Juliette Daher, Eric Prieur, Catherine Blanc, Jean-Louis Pérignon

Infect Immun· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The malaria candidate vaccine liver stage antigen-3 is highly conserved in Plasmodium falciparum isolates from diverse geographical areas.
Eric Prieur, Pierre Druilhe

Malar J· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses.
Eric Prieur, Sarah C Gilbert, Joerg Schneider, Anne C Moore, Eric G Sheu

Proc Natl Acad Sci U S A· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis